医疗、生命科学与医药

医疗、生命科学与医药领域机遇

医疗行业格局复杂，且随着技术与人工智能的进步持续演变。医疗与生命科学领域的创新催生了全新疗法、医药产品，以及医院和医疗服务机构可运用的各类新型能力。与此同时，人口结构变化与老龄化趋势正重塑全球医疗体系，全球医疗支出预计将从当前的 11.2 万亿美元增至 2050 年的 20.5 万亿美元[1]。

深刻洞悉不断发展的医疗行业

本所医疗、生命科学与医药业务组，依托各细分专业领域，竭诚为客户提供及时务实、覆盖多领域的综合性法律服务。团队成员均来自并购重组、网络安全、知识产权、保险、诉讼等各类商事业务领域资深专业人士，深耕医疗健康行业，经办过多项业内极具创新性与影响力的重大项目。

凭借深厚的行业积淀与贴合商业实操的服务思路，我们全程助力客户完成发展壮大与产业转型全流程布局，服务范围涵盖境内外并购交易、医疗行业合规监管、企业内部架构整合重组、各类商事协议拟定、医疗基建项目设立及日常经营合作协议起草等相关法律事务。

团队凭借丰富实务经验，依托诉讼与商事争议解决专业能力，为医疗、生命科学与医药领域客户处理各类复杂行业纠纷，囊括全赛道医疗执业责任纠纷、知识产权侵权诉讼等各类涉医争议案件。我们深谙此类敏感事务需秉持友好协商、严守保密、高效处置的处理原则，擅长为客户应对各类错综复杂的行业疑难局面出具专业法律意见。

贴合区域需求的务实方案

我们深知，当今世界互联互通，部分业务事项可能涉及多个司法管辖区。为此，本所医疗、生命科学与医药业务团队，获得安盛亚洲超 36 个专业业务组逾 650 名律师的鼎力支持。

依托这一资源，我们可组建跨领域专项团队，汇聚相关司法管辖区内的顶尖专家。因此，客户可信赖我们有能力综合全球最佳实践、行业领先企业制度与各地监管细则差异，为客户提供全方位专业建议。

Opportunities in healthcare, life sciences & pharmaceuticals

The healthcare landscape is complex and has continued to evolve with the advancement of technology and artificial intelligence. Innovation across healthcare and life sciences has given rise to new treatments, pharmaceuticals, and a host of other capabilities available to hospitals and healthcare service providers. At the same time, demographic shifts and ageing populations are reshaping healthcare systems worldwide, with global healthcare spending expected to reach $20.5 trillion in 2050, up from $11.2 trillion today.

Deep understanding of the evolving healthcare sector

Our Healthcare, Life Sciences & Pharmaceuticals Practice stands ready to provide clients with comprehensive, multidisciplinary advice that is both timely and practical across sub-specialty groups. Our Team is drawn from specialists in various corporate practice areas such as Mergers & Acquisitions, Cybersecurity, Intellectual Property, Insurance, and Litigation with deep and broad experience working on some of the most innovative and high-profile matters in healthcare.

With deep industry knowledge and a commercially focused approach, we support clients through every stage of growth and transformation. This includes advising on local or cross-border mergers & acquisitions, healthcare regulations and requirements, corporate reorganisation and restructuring, commercial agreements and contracts, establishment of healthcare infrastructure and other operational agreements.

Our Team is well positioned with extensive experience in advising healthcare, life sciences and pharmaceutical clients on complex healthcare-related disputes including professional liability disputes across the healthcare spectrum and IP infringement proceedings, tapping on our expertise in litigation and dispute resolution. We deeply understand the importance of resolving sensitive matters in an amicable, discreet, and timely manner, and are well placed to provide advice on handling intricate and highly complex situations.

Regionally relevant and practical advice

We also understand that the interconnectivity of our world means that some matters may take on a multi-jurisdictional nature. That is why our Healthcare, Life Sciences & Pharmaceuticals Practice is further supported by over 650 lawyers in more than 36 specialist practices across A&G Asia.

This enables our Team to assemble a multi-disciplinary task force composed of leading specialists in the jurisdictions involved. Clients can therefore be assured that in our ability to provide holistic advice that takes into consideration global best practices, industry leading corporate policies, and local regulatory nuances.

[1] https://www.mckinsey.com/mhi/our-insights/the-health-of-nations-stronger-health-stronger-economies